nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—CYP2D6—Hydroxyurea—psoriasis	0.0464	0.162	CbGbCtD
Pergolide—CYP3A4—Calcitriol—psoriasis	0.0347	0.121	CbGbCtD
Pergolide—CYP2D6—Cholecalciferol—psoriasis	0.0281	0.0981	CbGbCtD
Pergolide—CYP3A4—Methoxsalen—psoriasis	0.027	0.0942	CbGbCtD
Pergolide—CYP2D6—Cyclosporine—psoriasis	0.0185	0.0645	CbGbCtD
Pergolide—CYP3A4—Cholecalciferol—psoriasis	0.0179	0.0624	CbGbCtD
Pergolide—CYP3A4—Mycophenolate mofetil—psoriasis	0.0155	0.0541	CbGbCtD
Pergolide—CYP3A4—Triamcinolone—psoriasis	0.0155	0.0541	CbGbCtD
Pergolide—CYP3A4—Betamethasone—psoriasis	0.0133	0.0464	CbGbCtD
Pergolide—CYP3A4—Prednisolone—psoriasis	0.0131	0.0458	CbGbCtD
Pergolide—CYP3A4—Hydrocortisone—psoriasis	0.0124	0.0434	CbGbCtD
Pergolide—CYP3A4—Prednisone—psoriasis	0.0124	0.0433	CbGbCtD
Pergolide—CYP2D6—Dexamethasone—psoriasis	0.0122	0.0425	CbGbCtD
Pergolide—CYP3A4—Cyclosporine—psoriasis	0.0117	0.041	CbGbCtD
Pergolide—CYP3A4—Dexamethasone—psoriasis	0.00774	0.027	CbGbCtD
Pergolide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00015	0.000225	CcSEcCtD
Pergolide—Anorexia—Hydrocortisone—psoriasis	0.00015	0.000224	CcSEcCtD
Pergolide—Diarrhoea—Mycophenolic acid—psoriasis	0.00015	0.000224	CcSEcCtD
Pergolide—Conjunctivitis—Methotrexate—psoriasis	0.000149	0.000223	CcSEcCtD
Pergolide—Malaise—Dexamethasone—psoriasis	0.000149	0.000222	CcSEcCtD
Pergolide—Malaise—Betamethasone—psoriasis	0.000149	0.000222	CcSEcCtD
Pergolide—Oedema—Triamcinolone—psoriasis	0.000148	0.000222	CcSEcCtD
Pergolide—Vertigo—Dexamethasone—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Vertigo—Betamethasone—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Syncope—Dexamethasone—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Syncope—Betamethasone—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Pain—Mycophenolate mofetil—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Constipation—Mycophenolate mofetil—psoriasis	0.000148	0.000221	CcSEcCtD
Pergolide—Arrhythmia—Prednisone—psoriasis	0.000147	0.00022	CcSEcCtD
Pergolide—Infection—Triamcinolone—psoriasis	0.000147	0.00022	CcSEcCtD
Pergolide—Sweating—Methotrexate—psoriasis	0.000147	0.00022	CcSEcCtD
Pergolide—Hypotension—Hydrocortisone—psoriasis	0.000147	0.00022	CcSEcCtD
Pergolide—Haematuria—Methotrexate—psoriasis	0.000147	0.000219	CcSEcCtD
Pergolide—Feeling abnormal—Cyclosporine—psoriasis	0.000146	0.000218	CcSEcCtD
Pergolide—Shock—Triamcinolone—psoriasis	0.000146	0.000218	CcSEcCtD
Pergolide—Insomnia—Prednisolone—psoriasis	0.000146	0.000218	CcSEcCtD
Pergolide—Alopecia—Prednisone—psoriasis	0.000146	0.000218	CcSEcCtD
Pergolide—Gastrointestinal pain—Cyclosporine—psoriasis	0.000145	0.000217	CcSEcCtD
Pergolide—Loss of consciousness—Dexamethasone—psoriasis	0.000145	0.000217	CcSEcCtD
Pergolide—Loss of consciousness—Betamethasone—psoriasis	0.000145	0.000217	CcSEcCtD
Pergolide—Dizziness—Mycophenolic acid—psoriasis	0.000145	0.000217	CcSEcCtD
Pergolide—Epistaxis—Methotrexate—psoriasis	0.000145	0.000216	CcSEcCtD
Pergolide—Paraesthesia—Prednisolone—psoriasis	0.000145	0.000216	CcSEcCtD
Pergolide—Tachycardia—Triamcinolone—psoriasis	0.000145	0.000216	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000144	0.000214	CcSEcCtD
Pergolide—Hyperhidrosis—Triamcinolone—psoriasis	0.000144	0.000214	CcSEcCtD
Pergolide—Convulsion—Dexamethasone—psoriasis	0.000143	0.000214	CcSEcCtD
Pergolide—Convulsion—Betamethasone—psoriasis	0.000143	0.000214	CcSEcCtD
Pergolide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000143	0.000213	CcSEcCtD
Pergolide—Insomnia—Hydrocortisone—psoriasis	0.000143	0.000213	CcSEcCtD
Pergolide—Hypertension—Betamethasone—psoriasis	0.000142	0.000213	CcSEcCtD
Pergolide—Hypertension—Dexamethasone—psoriasis	0.000142	0.000213	CcSEcCtD
Pergolide—Paraesthesia—Hydrocortisone—psoriasis	0.000142	0.000211	CcSEcCtD
Pergolide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000141	0.000211	CcSEcCtD
Pergolide—Myalgia—Dexamethasone—psoriasis	0.00014	0.00021	CcSEcCtD
Pergolide—Myalgia—Betamethasone—psoriasis	0.00014	0.00021	CcSEcCtD
Pergolide—Body temperature increased—Cyclosporine—psoriasis	0.00014	0.000209	CcSEcCtD
Pergolide—Abdominal pain—Cyclosporine—psoriasis	0.00014	0.000209	CcSEcCtD
Pergolide—Anxiety—Dexamethasone—psoriasis	0.00014	0.000209	CcSEcCtD
Pergolide—Anxiety—Betamethasone—psoriasis	0.00014	0.000209	CcSEcCtD
Pergolide—Vomiting—Mycophenolic acid—psoriasis	0.000139	0.000208	CcSEcCtD
Pergolide—Discomfort—Dexamethasone—psoriasis	0.000139	0.000207	CcSEcCtD
Pergolide—Discomfort—Betamethasone—psoriasis	0.000139	0.000207	CcSEcCtD
Pergolide—Dyspepsia—Hydrocortisone—psoriasis	0.000139	0.000207	CcSEcCtD
Pergolide—Rash—Mycophenolic acid—psoriasis	0.000138	0.000206	CcSEcCtD
Pergolide—Dermatitis—Mycophenolic acid—psoriasis	0.000138	0.000206	CcSEcCtD
Pergolide—Pain—Prednisolone—psoriasis	0.000138	0.000206	CcSEcCtD
Pergolide—Hepatitis—Methotrexate—psoriasis	0.000138	0.000206	CcSEcCtD
Pergolide—Headache—Mycophenolic acid—psoriasis	0.000137	0.000205	CcSEcCtD
Pergolide—Decreased appetite—Hydrocortisone—psoriasis	0.000137	0.000205	CcSEcCtD
Pergolide—Pharyngitis—Methotrexate—psoriasis	0.000137	0.000204	CcSEcCtD
Pergolide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000137	0.000204	CcSEcCtD
Pergolide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000137	0.000204	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000135	0.000202	CcSEcCtD
Pergolide—Pain—Hydrocortisone—psoriasis	0.000135	0.000201	CcSEcCtD
Pergolide—Oedema—Betamethasone—psoriasis	0.000135	0.000201	CcSEcCtD
Pergolide—Oedema—Dexamethasone—psoriasis	0.000135	0.000201	CcSEcCtD
Pergolide—Insomnia—Triamcinolone—psoriasis	0.000134	0.0002	CcSEcCtD
Pergolide—Infection—Betamethasone—psoriasis	0.000134	0.0002	CcSEcCtD
Pergolide—Infection—Dexamethasone—psoriasis	0.000134	0.0002	CcSEcCtD
Pergolide—Ill-defined disorder—Prednisone—psoriasis	0.000133	0.000199	CcSEcCtD
Pergolide—Paraesthesia—Triamcinolone—psoriasis	0.000133	0.000199	CcSEcCtD
Pergolide—Feeling abnormal—Prednisolone—psoriasis	0.000133	0.000199	CcSEcCtD
Pergolide—Visual impairment—Methotrexate—psoriasis	0.000133	0.000199	CcSEcCtD
Pergolide—Anaemia—Prednisone—psoriasis	0.000133	0.000198	CcSEcCtD
Pergolide—Shock—Betamethasone—psoriasis	0.000133	0.000198	CcSEcCtD
Pergolide—Shock—Dexamethasone—psoriasis	0.000133	0.000198	CcSEcCtD
Pergolide—Dyspnoea—Triamcinolone—psoriasis	0.000132	0.000198	CcSEcCtD
Pergolide—Agitation—Prednisone—psoriasis	0.000132	0.000197	CcSEcCtD
Pergolide—Thrombocytopenia—Dexamethasone—psoriasis	0.000132	0.000197	CcSEcCtD
Pergolide—Thrombocytopenia—Betamethasone—psoriasis	0.000132	0.000197	CcSEcCtD
Pergolide—Tachycardia—Dexamethasone—psoriasis	0.000131	0.000196	CcSEcCtD
Pergolide—Tachycardia—Betamethasone—psoriasis	0.000131	0.000196	CcSEcCtD
Pergolide—Dyspepsia—Triamcinolone—psoriasis	0.000131	0.000195	CcSEcCtD
Pergolide—Nausea—Mycophenolic acid—psoriasis	0.00013	0.000194	CcSEcCtD
Pergolide—Hyperhidrosis—Dexamethasone—psoriasis	0.00013	0.000194	CcSEcCtD
Pergolide—Hyperhidrosis—Betamethasone—psoriasis	0.00013	0.000194	CcSEcCtD
Pergolide—Feeling abnormal—Hydrocortisone—psoriasis	0.00013	0.000194	CcSEcCtD
Pergolide—Malaise—Prednisone—psoriasis	0.00013	0.000194	CcSEcCtD
Pergolide—Vertigo—Prednisone—psoriasis	0.000129	0.000193	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—psoriasis	0.000129	0.000193	CcSEcCtD
Pergolide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000129	0.000192	CcSEcCtD
Pergolide—Syncope—Prednisone—psoriasis	0.000129	0.000192	CcSEcCtD
Pergolide—Tinnitus—Methotrexate—psoriasis	0.000129	0.000192	CcSEcCtD
Pergolide—Anorexia—Dexamethasone—psoriasis	0.000128	0.000192	CcSEcCtD
Pergolide—Anorexia—Betamethasone—psoriasis	0.000128	0.000192	CcSEcCtD
Pergolide—Asthenia—Cyclosporine—psoriasis	0.000127	0.00019	CcSEcCtD
Pergolide—Pain—Triamcinolone—psoriasis	0.000127	0.00019	CcSEcCtD
Pergolide—Loss of consciousness—Prednisone—psoriasis	0.000126	0.000189	CcSEcCtD
Pergolide—Hypotension—Dexamethasone—psoriasis	0.000126	0.000188	CcSEcCtD
Pergolide—Hypotension—Betamethasone—psoriasis	0.000126	0.000188	CcSEcCtD
Pergolide—Pruritus—Cyclosporine—psoriasis	0.000125	0.000187	CcSEcCtD
Pergolide—Body temperature increased—Hydrocortisone—psoriasis	0.000125	0.000186	CcSEcCtD
Pergolide—Abdominal pain—Hydrocortisone—psoriasis	0.000125	0.000186	CcSEcCtD
Pergolide—Convulsion—Prednisone—psoriasis	0.000125	0.000186	CcSEcCtD
Pergolide—Asthenia—Mycophenolate mofetil—psoriasis	0.000124	0.000185	CcSEcCtD
Pergolide—Hypertension—Prednisone—psoriasis	0.000124	0.000185	CcSEcCtD
Pergolide—Chills—Methotrexate—psoriasis	0.000124	0.000185	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000123	0.000183	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000123	0.000183	CcSEcCtD
Pergolide—Pruritus—Mycophenolate mofetil—psoriasis	0.000122	0.000183	CcSEcCtD
Pergolide—Myalgia—Prednisone—psoriasis	0.000122	0.000183	CcSEcCtD
Pergolide—Arthralgia—Prednisone—psoriasis	0.000122	0.000183	CcSEcCtD
Pergolide—Feeling abnormal—Triamcinolone—psoriasis	0.000122	0.000183	CcSEcCtD
Pergolide—Anxiety—Prednisone—psoriasis	0.000122	0.000182	CcSEcCtD
Pergolide—Alopecia—Methotrexate—psoriasis	0.000122	0.000182	CcSEcCtD
Pergolide—Insomnia—Betamethasone—psoriasis	0.000122	0.000182	CcSEcCtD
Pergolide—Insomnia—Dexamethasone—psoriasis	0.000122	0.000182	CcSEcCtD
Pergolide—Diarrhoea—Cyclosporine—psoriasis	0.000121	0.000181	CcSEcCtD
Pergolide—Paraesthesia—Dexamethasone—psoriasis	0.000121	0.000181	CcSEcCtD
Pergolide—Paraesthesia—Betamethasone—psoriasis	0.000121	0.000181	CcSEcCtD
Pergolide—Discomfort—Prednisone—psoriasis	0.000121	0.000181	CcSEcCtD
Pergolide—Dyspepsia—Dexamethasone—psoriasis	0.000119	0.000177	CcSEcCtD
Pergolide—Dyspepsia—Betamethasone—psoriasis	0.000119	0.000177	CcSEcCtD
Pergolide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000118	0.000177	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—psoriasis	0.000118	0.000176	CcSEcCtD
Pergolide—Body temperature increased—Triamcinolone—psoriasis	0.000117	0.000175	CcSEcCtD
Pergolide—Dizziness—Cyclosporine—psoriasis	0.000117	0.000175	CcSEcCtD
Pergolide—Oedema—Prednisone—psoriasis	0.000117	0.000175	CcSEcCtD
Pergolide—Decreased appetite—Betamethasone—psoriasis	0.000117	0.000175	CcSEcCtD
Pergolide—Decreased appetite—Dexamethasone—psoriasis	0.000117	0.000175	CcSEcCtD
Pergolide—Infection—Prednisone—psoriasis	0.000117	0.000174	CcSEcCtD
Pergolide—Back pain—Methotrexate—psoriasis	0.000116	0.000173	CcSEcCtD
Pergolide—Shock—Prednisone—psoriasis	0.000115	0.000172	CcSEcCtD
Pergolide—Pain—Dexamethasone—psoriasis	0.000115	0.000172	CcSEcCtD
Pergolide—Pain—Betamethasone—psoriasis	0.000115	0.000172	CcSEcCtD
Pergolide—Tachycardia—Prednisone—psoriasis	0.000114	0.000171	CcSEcCtD
Pergolide—Dizziness—Mycophenolate mofetil—psoriasis	0.000114	0.000171	CcSEcCtD
Pergolide—Hyperhidrosis—Prednisone—psoriasis	0.000113	0.000169	CcSEcCtD
Pergolide—Asthenia—Hydrocortisone—psoriasis	0.000113	0.000169	CcSEcCtD
Pergolide—Vomiting—Cyclosporine—psoriasis	0.000113	0.000168	CcSEcCtD
Pergolide—Rash—Cyclosporine—psoriasis	0.000112	0.000167	CcSEcCtD
Pergolide—Anorexia—Prednisone—psoriasis	0.000112	0.000167	CcSEcCtD
Pergolide—Dermatitis—Cyclosporine—psoriasis	0.000112	0.000167	CcSEcCtD
Pergolide—Pruritus—Hydrocortisone—psoriasis	0.000112	0.000167	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—psoriasis	0.000111	0.000166	CcSEcCtD
Pergolide—Headache—Cyclosporine—psoriasis	0.000111	0.000166	CcSEcCtD
Pergolide—Anaemia—Methotrexate—psoriasis	0.000111	0.000166	CcSEcCtD
Pergolide—Feeling abnormal—Betamethasone—psoriasis	0.000111	0.000166	CcSEcCtD
Pergolide—Feeling abnormal—Dexamethasone—psoriasis	0.000111	0.000166	CcSEcCtD
Pergolide—Gastrointestinal pain—Betamethasone—psoriasis	0.00011	0.000164	CcSEcCtD
Pergolide—Gastrointestinal pain—Dexamethasone—psoriasis	0.00011	0.000164	CcSEcCtD
Pergolide—Vomiting—Mycophenolate mofetil—psoriasis	0.00011	0.000164	CcSEcCtD
Pergolide—Rash—Mycophenolate mofetil—psoriasis	0.000109	0.000163	CcSEcCtD
Pergolide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000109	0.000163	CcSEcCtD
Pergolide—Headache—Mycophenolate mofetil—psoriasis	0.000108	0.000162	CcSEcCtD
Pergolide—Malaise—Methotrexate—psoriasis	0.000108	0.000162	CcSEcCtD
Pergolide—Vertigo—Methotrexate—psoriasis	0.000108	0.000161	CcSEcCtD
Pergolide—Diarrhoea—Hydrocortisone—psoriasis	0.000108	0.000161	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—psoriasis	0.000108	0.000161	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Prednisone—psoriasis	0.000107	0.00016	CcSEcCtD
Pergolide—Dizziness—Prednisolone—psoriasis	0.000107	0.000159	CcSEcCtD
Pergolide—Asthenia—Triamcinolone—psoriasis	0.000107	0.000159	CcSEcCtD
Pergolide—Abdominal pain—Betamethasone—psoriasis	0.000106	0.000159	CcSEcCtD
Pergolide—Body temperature increased—Betamethasone—psoriasis	0.000106	0.000159	CcSEcCtD
Pergolide—Body temperature increased—Dexamethasone—psoriasis	0.000106	0.000159	CcSEcCtD
Pergolide—Abdominal pain—Dexamethasone—psoriasis	0.000106	0.000159	CcSEcCtD
Pergolide—Insomnia—Prednisone—psoriasis	0.000106	0.000158	CcSEcCtD
Pergolide—Nausea—Cyclosporine—psoriasis	0.000105	0.000157	CcSEcCtD
Pergolide—Paraesthesia—Prednisone—psoriasis	0.000105	0.000157	CcSEcCtD
Pergolide—Pruritus—Triamcinolone—psoriasis	0.000105	0.000157	CcSEcCtD
Pergolide—Cough—Methotrexate—psoriasis	0.000105	0.000157	CcSEcCtD
Pergolide—Dizziness—Hydrocortisone—psoriasis	0.000104	0.000156	CcSEcCtD
Pergolide—Convulsion—Methotrexate—psoriasis	0.000104	0.000155	CcSEcCtD
Pergolide—Dyspepsia—Prednisone—psoriasis	0.000103	0.000154	CcSEcCtD
Pergolide—Nausea—Mycophenolate mofetil—psoriasis	0.000103	0.000153	CcSEcCtD
Pergolide—Myalgia—Methotrexate—psoriasis	0.000102	0.000153	CcSEcCtD
Pergolide—Chest pain—Methotrexate—psoriasis	0.000102	0.000153	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—psoriasis	0.000102	0.000153	CcSEcCtD
Pergolide—Decreased appetite—Prednisone—psoriasis	0.000102	0.000152	CcSEcCtD
Pergolide—Rash—Prednisolone—psoriasis	0.000102	0.000152	CcSEcCtD
Pergolide—Dermatitis—Prednisolone—psoriasis	0.000102	0.000152	CcSEcCtD
Pergolide—Headache—Prednisolone—psoriasis	0.000101	0.000151	CcSEcCtD
Pergolide—Discomfort—Methotrexate—psoriasis	0.000101	0.000151	CcSEcCtD
Pergolide—Constipation—Prednisone—psoriasis	0.0001	0.00015	CcSEcCtD
Pergolide—Vomiting—Hydrocortisone—psoriasis	0.0001	0.00015	CcSEcCtD
Pergolide—Rash—Hydrocortisone—psoriasis	9.94e-05	0.000148	CcSEcCtD
Pergolide—Dermatitis—Hydrocortisone—psoriasis	9.93e-05	0.000148	CcSEcCtD
Pergolide—Confusional state—Methotrexate—psoriasis	9.88e-05	0.000148	CcSEcCtD
Pergolide—Headache—Hydrocortisone—psoriasis	9.88e-05	0.000147	CcSEcCtD
Pergolide—Dizziness—Triamcinolone—psoriasis	9.82e-05	0.000147	CcSEcCtD
Pergolide—Infection—Methotrexate—psoriasis	9.74e-05	0.000145	CcSEcCtD
Pergolide—Feeling abnormal—Prednisone—psoriasis	9.67e-05	0.000144	CcSEcCtD
Pergolide—Asthenia—Dexamethasone—psoriasis	9.66e-05	0.000144	CcSEcCtD
Pergolide—Asthenia—Betamethasone—psoriasis	9.66e-05	0.000144	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—psoriasis	9.6e-05	0.000143	CcSEcCtD
Pergolide—Gastrointestinal pain—Prednisone—psoriasis	9.59e-05	0.000143	CcSEcCtD
Pergolide—Nausea—Prednisolone—psoriasis	9.59e-05	0.000143	CcSEcCtD
Pergolide—Pruritus—Dexamethasone—psoriasis	9.53e-05	0.000142	CcSEcCtD
Pergolide—Pruritus—Betamethasone—psoriasis	9.53e-05	0.000142	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—psoriasis	9.48e-05	0.000142	CcSEcCtD
Pergolide—Vomiting—Triamcinolone—psoriasis	9.44e-05	0.000141	CcSEcCtD
Pergolide—Nausea—Hydrocortisone—psoriasis	9.36e-05	0.00014	CcSEcCtD
Pergolide—Rash—Triamcinolone—psoriasis	9.36e-05	0.00014	CcSEcCtD
Pergolide—Dermatitis—Triamcinolone—psoriasis	9.35e-05	0.00014	CcSEcCtD
Pergolide—Anorexia—Methotrexate—psoriasis	9.34e-05	0.00014	CcSEcCtD
Pergolide—Headache—Triamcinolone—psoriasis	9.3e-05	0.000139	CcSEcCtD
Pergolide—Abdominal pain—Prednisone—psoriasis	9.27e-05	0.000138	CcSEcCtD
Pergolide—Body temperature increased—Prednisone—psoriasis	9.27e-05	0.000138	CcSEcCtD
Pergolide—Diarrhoea—Betamethasone—psoriasis	9.22e-05	0.000138	CcSEcCtD
Pergolide—Diarrhoea—Dexamethasone—psoriasis	9.22e-05	0.000138	CcSEcCtD
Pergolide—Hypotension—Methotrexate—psoriasis	9.16e-05	0.000137	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—psoriasis	8.93e-05	0.000133	CcSEcCtD
Pergolide—Dizziness—Dexamethasone—psoriasis	8.91e-05	0.000133	CcSEcCtD
Pergolide—Dizziness—Betamethasone—psoriasis	8.91e-05	0.000133	CcSEcCtD
Pergolide—Insomnia—Methotrexate—psoriasis	8.87e-05	0.000132	CcSEcCtD
Pergolide—Nausea—Triamcinolone—psoriasis	8.82e-05	0.000132	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—psoriasis	8.8e-05	0.000131	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—psoriasis	8.74e-05	0.00013	CcSEcCtD
Pergolide—Somnolence—Methotrexate—psoriasis	8.71e-05	0.00013	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—psoriasis	8.63e-05	0.000129	CcSEcCtD
Pergolide—Vomiting—Betamethasone—psoriasis	8.56e-05	0.000128	CcSEcCtD
Pergolide—Vomiting—Dexamethasone—psoriasis	8.56e-05	0.000128	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—psoriasis	8.52e-05	0.000127	CcSEcCtD
Pergolide—Rash—Dexamethasone—psoriasis	8.49e-05	0.000127	CcSEcCtD
Pergolide—Rash—Betamethasone—psoriasis	8.49e-05	0.000127	CcSEcCtD
Pergolide—Dermatitis—Betamethasone—psoriasis	8.48e-05	0.000127	CcSEcCtD
Pergolide—Dermatitis—Dexamethasone—psoriasis	8.48e-05	0.000127	CcSEcCtD
Pergolide—Headache—Dexamethasone—psoriasis	8.44e-05	0.000126	CcSEcCtD
Pergolide—Headache—Betamethasone—psoriasis	8.44e-05	0.000126	CcSEcCtD
Pergolide—Asthenia—Prednisone—psoriasis	8.42e-05	0.000126	CcSEcCtD
Pergolide—Pain—Methotrexate—psoriasis	8.38e-05	0.000125	CcSEcCtD
Pergolide—Pruritus—Prednisone—psoriasis	8.3e-05	0.000124	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—psoriasis	8.08e-05	0.000121	CcSEcCtD
Pergolide—Diarrhoea—Prednisone—psoriasis	8.03e-05	0.00012	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—psoriasis	8.02e-05	0.00012	CcSEcCtD
Pergolide—Nausea—Dexamethasone—psoriasis	8e-05	0.000119	CcSEcCtD
Pergolide—Nausea—Betamethasone—psoriasis	8e-05	0.000119	CcSEcCtD
Pergolide—Dizziness—Prednisone—psoriasis	7.76e-05	0.000116	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—psoriasis	7.75e-05	0.000116	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—psoriasis	7.75e-05	0.000116	CcSEcCtD
Pergolide—Vomiting—Prednisone—psoriasis	7.46e-05	0.000111	CcSEcCtD
Pergolide—Rash—Prednisone—psoriasis	7.4e-05	0.00011	CcSEcCtD
Pergolide—Dermatitis—Prednisone—psoriasis	7.39e-05	0.00011	CcSEcCtD
Pergolide—Headache—Prednisone—psoriasis	7.35e-05	0.00011	CcSEcCtD
Pergolide—Asthenia—Methotrexate—psoriasis	7.03e-05	0.000105	CcSEcCtD
Pergolide—Nausea—Prednisone—psoriasis	6.97e-05	0.000104	CcSEcCtD
Pergolide—Pruritus—Methotrexate—psoriasis	6.94e-05	0.000104	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—psoriasis	6.71e-05	0.0001	CcSEcCtD
Pergolide—Dizziness—Methotrexate—psoriasis	6.48e-05	9.68e-05	CcSEcCtD
Pergolide—Vomiting—Methotrexate—psoriasis	6.23e-05	9.31e-05	CcSEcCtD
Pergolide—Rash—Methotrexate—psoriasis	6.18e-05	9.23e-05	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—psoriasis	6.18e-05	9.22e-05	CcSEcCtD
Pergolide—Headache—Methotrexate—psoriasis	6.14e-05	9.17e-05	CcSEcCtD
Pergolide—Nausea—Methotrexate—psoriasis	5.82e-05	8.69e-05	CcSEcCtD
Pergolide—HTR1B—Signaling Pathways—APOE—psoriasis	1.46e-05	0.000332	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—LEP—psoriasis	1.46e-05	0.000332	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SOCS1—psoriasis	1.45e-05	0.000332	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—CXCL8—psoriasis	1.45e-05	0.000331	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—APOE—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—LEP—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.43e-05	0.000327	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.42e-05	0.000325	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	1.42e-05	0.000325	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CARM1—psoriasis	1.42e-05	0.000324	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—VEGFA—psoriasis	1.39e-05	0.000317	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.39e-05	0.000316	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.38e-05	0.000316	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—TP53—psoriasis	1.38e-05	0.000315	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.37e-05	0.000314	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—APOE—psoriasis	1.37e-05	0.000312	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—LEP—psoriasis	1.37e-05	0.000312	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.37e-05	0.000312	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.36e-05	0.000311	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—NFKBIA—psoriasis	1.36e-05	0.00031	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CAT—psoriasis	1.34e-05	0.000306	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—NFKBIA—psoriasis	1.33e-05	0.000305	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	1.33e-05	0.000303	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SOCS1—psoriasis	1.32e-05	0.000301	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.31e-05	0.000299	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.3e-05	0.000296	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	1.29e-05	0.000295	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—TP53—psoriasis	1.29e-05	0.000295	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CXCL8—psoriasis	1.29e-05	0.000294	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—APOE—psoriasis	1.29e-05	0.000294	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—LEP—psoriasis	1.29e-05	0.000294	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—APOE—psoriasis	1.28e-05	0.000293	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.27e-05	0.000291	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—LEP—psoriasis	1.27e-05	0.00029	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—LEP—psoriasis	1.27e-05	0.00029	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—APOE—psoriasis	1.27e-05	0.00029	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—APOE—psoriasis	1.27e-05	0.00029	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.27e-05	0.00029	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000287	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.25e-05	0.000285	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.24e-05	0.000283	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.24e-05	0.000283	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—psoriasis	1.23e-05	0.00028	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.21e-05	0.000277	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.21e-05	0.000276	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000275	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.2e-05	0.000274	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—JUN—psoriasis	1.2e-05	0.000274	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.18e-05	0.00027	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.16e-05	0.000265	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—NFKB1—psoriasis	1.15e-05	0.000263	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000262	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000262	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TYK2—psoriasis	1.13e-05	0.000259	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.13e-05	0.000257	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PPARG—psoriasis	1.12e-05	0.000255	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TYK2—psoriasis	1.11e-05	0.000254	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—LEP—psoriasis	1.11e-05	0.000253	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—APOE—psoriasis	1.11e-05	0.000253	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—LEP—psoriasis	1.1e-05	0.000252	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—APOE—psoriasis	1.1e-05	0.000252	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.09e-05	0.00025	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TYK2—psoriasis	1.09e-05	0.00025	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.08e-05	0.000246	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.08e-05	0.000246	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—LEP—psoriasis	1.07e-05	0.000245	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—APOE—psoriasis	1.07e-05	0.000245	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000244	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—LEP—psoriasis	1.06e-05	0.000241	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—APOE—psoriasis	1.06e-05	0.000241	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000241	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—psoriasis	1.05e-05	0.000239	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—VEGFA—psoriasis	1.05e-05	0.000239	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TYK2—psoriasis	1.04e-05	0.000238	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—APOE—psoriasis	1.04e-05	0.000238	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—STAT3—psoriasis	1.04e-05	0.000237	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000236	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000235	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	1e-05	0.000228	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CXCL8—psoriasis	9.88e-06	0.000226	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TYK2—psoriasis	9.84e-06	0.000225	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	9.84e-06	0.000225	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	9.8e-06	0.000224	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—LEP—psoriasis	9.73e-06	0.000222	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—APOE—psoriasis	9.73e-06	0.000222	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TYK2—psoriasis	9.71e-06	0.000222	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TYK2—psoriasis	9.71e-06	0.000222	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CXCL8—psoriasis	9.67e-06	0.000221	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—APOE—psoriasis	9.58e-06	0.000219	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—LEP—psoriasis	9.58e-06	0.000219	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CXCL8—psoriasis	9.52e-06	0.000217	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—psoriasis	9.39e-06	0.000214	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—LEP—psoriasis	9.38e-06	0.000214	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—APOE—psoriasis	9.38e-06	0.000214	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CARM1—psoriasis	9.29e-06	0.000212	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—psoriasis	9.2e-06	0.00021	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—JUN—psoriasis	9.18e-06	0.00021	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CXCL8—psoriasis	9.08e-06	0.000207	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PPARG—psoriasis	9.08e-06	0.000207	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NFKBIA—psoriasis	9.07e-06	0.000207	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—psoriasis	9.05e-06	0.000207	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—JUN—psoriasis	8.99e-06	0.000205	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NFKBIA—psoriasis	8.92e-06	0.000204	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—JUN—psoriasis	8.85e-06	0.000202	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—NFKB1—psoriasis	8.84e-06	0.000202	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TYK2—psoriasis	8.77e-06	0.0002	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CAT—psoriasis	8.74e-06	0.0002	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	8.74e-06	0.0002	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—APOE—psoriasis	8.71e-06	0.000199	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—LEP—psoriasis	8.71e-06	0.000199	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—NFKB1—psoriasis	8.65e-06	0.000198	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—psoriasis	8.64e-06	0.000197	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CXCL8—psoriasis	8.57e-06	0.000196	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—NFKB1—psoriasis	8.52e-06	0.000194	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TYK2—psoriasis	8.46e-06	0.000193	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CXCL8—psoriasis	8.45e-06	0.000193	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCL8—psoriasis	8.45e-06	0.000193	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—JUN—psoriasis	8.45e-06	0.000193	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TYK2—psoriasis	8.42e-06	0.000192	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TYK2—psoriasis	8.19e-06	0.000187	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—psoriasis	8.15e-06	0.000186	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—NFKB1—psoriasis	8.13e-06	0.000186	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	8.12e-06	0.000185	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TYK2—psoriasis	8.06e-06	0.000184	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—psoriasis	8.04e-06	0.000184	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—psoriasis	8.04e-06	0.000184	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VEGFA—psoriasis	8.02e-06	0.000183	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—JUN—psoriasis	7.96e-06	0.000182	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—STAT3—psoriasis	7.94e-06	0.000181	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—psoriasis	7.91e-06	0.000181	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—JUN—psoriasis	7.86e-06	0.000179	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—JUN—psoriasis	7.86e-06	0.000179	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—psoriasis	7.85e-06	0.000179	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—STAT3—psoriasis	7.78e-06	0.000178	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—psoriasis	7.73e-06	0.000176	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NFKB1—psoriasis	7.67e-06	0.000175	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—STAT3—psoriasis	7.65e-06	0.000175	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL8—psoriasis	7.63e-06	0.000174	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NFKB1—psoriasis	7.56e-06	0.000173	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NFKB1—psoriasis	7.56e-06	0.000173	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TYK2—psoriasis	7.43e-06	0.00017	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—psoriasis	7.38e-06	0.000168	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.37e-06	0.000168	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL8—psoriasis	7.33e-06	0.000167	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TYK2—psoriasis	7.31e-06	0.000167	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—STAT3—psoriasis	7.31e-06	0.000167	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—psoriasis	7.26e-06	0.000166	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—psoriasis	7.24e-06	0.000165	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TYK2—psoriasis	7.16e-06	0.000163	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL8—psoriasis	7.13e-06	0.000163	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—JUN—psoriasis	7.09e-06	0.000162	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL8—psoriasis	7.02e-06	0.00016	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—psoriasis	7.01e-06	0.00016	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—psoriasis	6.97e-06	0.000159	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—psoriasis	6.96e-06	0.000159	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—STAT3—psoriasis	6.89e-06	0.000157	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.87e-06	0.000157	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—psoriasis	6.87e-06	0.000157	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—JUN—psoriasis	6.85e-06	0.000156	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NFKB1—psoriasis	6.83e-06	0.000156	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—JUN—psoriasis	6.81e-06	0.000156	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—psoriasis	6.8e-06	0.000155	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—psoriasis	6.8e-06	0.000155	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOE—psoriasis	6.79e-06	0.000155	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—psoriasis	6.78e-06	0.000155	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.67e-06	0.000152	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.65e-06	0.000152	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—JUN—psoriasis	6.63e-06	0.000151	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.59e-06	0.000151	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NFKB1—psoriasis	6.56e-06	0.00015	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—JUN—psoriasis	6.52e-06	0.000149	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—psoriasis	6.47e-06	0.000148	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NFKB1—psoriasis	6.38e-06	0.000146	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.36e-06	0.000145	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.28e-06	0.000143	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—psoriasis	6.23e-06	0.000142	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—psoriasis	6.2e-06	0.000142	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—psoriasis	6.15e-06	0.00014	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—psoriasis	6.14e-06	0.00014	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—psoriasis	6.06e-06	0.000138	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—psoriasis	6.05e-06	0.000138	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JUN—psoriasis	6.01e-06	0.000137	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.98e-06	0.000137	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.95e-06	0.000136	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—psoriasis	5.93e-06	0.000136	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.93e-06	0.000135	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—psoriasis	5.92e-06	0.000135	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JUN—psoriasis	5.92e-06	0.000135	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—psoriasis	5.91e-06	0.000135	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—psoriasis	5.89e-06	0.000135	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—psoriasis	5.84e-06	0.000133	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JUN—psoriasis	5.79e-06	0.000132	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.79e-06	0.000132	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—psoriasis	5.79e-06	0.000132	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NFKB1—psoriasis	5.79e-06	0.000132	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—psoriasis	5.73e-06	0.000131	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAT—psoriasis	5.71e-06	0.00013	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.7e-06	0.00013	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.7e-06	0.00013	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.64e-06	0.000129	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.58e-06	0.000127	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—psoriasis	5.58e-06	0.000127	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—psoriasis	5.55e-06	0.000127	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—psoriasis	5.51e-06	0.000126	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—psoriasis	5.43e-06	0.000124	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JUN—psoriasis	5.38e-06	0.000123	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—psoriasis	5.35e-06	0.000122	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—psoriasis	5.26e-06	0.00012	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—psoriasis	5.25e-06	0.00012	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—psoriasis	5.2e-06	0.000119	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—psoriasis	5.19e-06	0.000118	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—psoriasis	5.19e-06	0.000118	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.18e-06	0.000118	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.17e-06	0.000118	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—psoriasis	5.12e-06	0.000117	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—psoriasis	5.1e-06	0.000117	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5.06e-06	0.000116	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—psoriasis	5.01e-06	0.000114	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—psoriasis	4.81e-06	0.00011	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—psoriasis	4.75e-06	0.000108	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—psoriasis	4.75e-06	0.000108	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.7e-06	0.000107	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—psoriasis	4.68e-06	0.000107	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.66e-06	0.000106	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—psoriasis	4.52e-06	0.000103	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—psoriasis	4.5e-06	0.000103	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOE—psoriasis	4.44e-06	0.000101	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—psoriasis	4.37e-06	9.99e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—psoriasis	4.31e-06	9.83e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—psoriasis	4.29e-06	9.79e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—psoriasis	4.14e-06	9.45e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—psoriasis	4.12e-06	9.4e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—psoriasis	4e-06	9.14e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—psoriasis	3.97e-06	9.06e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—psoriasis	3.94e-06	9e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—psoriasis	3.91e-06	8.92e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—psoriasis	3.87e-06	8.83e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—psoriasis	3.82e-06	8.73e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—psoriasis	3.63e-06	8.3e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—psoriasis	3.58e-06	8.16e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—psoriasis	3.55e-06	8.11e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—psoriasis	3.5e-06	7.99e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—psoriasis	3.25e-06	7.43e-05	CbGpPWpGaD
